Intention of Early Redemption

RNS Number : 2742Z
Banco Santander S.A.
09 January 2020
 

 

 

 

 

Banco Santander, S.A. ("Banco Santander" or the "Issuer"), in compliance with the Securities Market legislation, hereby communicates the following:

 

 

INSIDE INFORMATION

 

In connection with the issue of Series I/2014 Non-Step-Up Non-Cumulative Contingent Convertible Perpetual Preferred Tier 1 Securities, with a nominal total value of one thousand five hundred million euros (EUR 1,500,000,000), with ISIN code XS1043535092 and common code 104353509, which remain outstanding and are traded on the Global Exchange Market of the Irish Stock Exchange (the "CoCos"), Banco Santander announces its intention to carry out the voluntary early redemption of all of the outstanding CoCos on the next payment date of the corresponding distribution falling on 12 March 2020.

 

The early redemption of all of the outstanding CoCos shall be agreed, if applicable, once the Issuer has carried out one or more new issues of additional tier 1 capital instruments for at least the same total nominal amount as the CoCos, and subject in any event to the Conditions of the Preferred Securities of the relevant prospectus of the CoCos (Offering Circular dated 6 March 2014) (the "Terms and Conditions") and the other conditions set out in the prior authorisation of the European Central Bank, which has already been obtained.

 

The Issuer's irrevocable decision to exercise the optional early redemption right would be communicated, if any, to the holders of the CoCos by means of a material fact announcement and other foreseen notices, in the form, within the required timeframe (i.e., from and including 12 January 2020 to and including 11 February 2020) and for the purposes set out in conditions 6 and 11 of the Terms and Conditions.

 

 

Boadilla del Monte (Madrid), 9 January  2020

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAPFNEESEEEA
UK 100

Latest directors dealings